Skip to main content
PMC home page
Journal of Medical Genetics logoLink to Journal of Medical Genetics
. 1992 Nov;29(11):791–793. doi: 10.1136/jmg.29.11.791

Intestinal pseudo-obstruction in myotonic dystrophy.

H G Brunner 1, B C Hamel 1, P Rieu 1, C J Höweler 1, F T Peters 1
PMCID: PMC1016174  PMID: 1453429

Abstract

We describe four myotonic dystrophy (DM) patients who developed recurrent intestinal pseudo-obstruction. Some episodes were associated with gastroenteritis, while abdominal crowding may have occurred in one case during the third trimester of pregnancy. In most instances, however, no apparent cause could be identified. Intestinal pseudo-obstruction may occur at any stage of DM. In one of our cases intestinal pseudo-obstruction preceded significant muscle weakness by 15 years. Intestinal pseudo-obstruction is usually treated effectively with conservative measures. These include restriction of oral intake, intravenous fluids, and multiple enemas or colonoscopy. Improved intestinal function was noted in one case treated with the prokinetic agent cisapride. A partial sigmoid resection was performed in three cases with dolichomegacolon. No abnormalities were reported on histological examination. Since intestinal pseudo-obstruction is a rare complication of DM, it is of interest that two of our cases are sibs. Review of published reports showed several reports of familial occurrence of specific complications. These include cardiac conduction disturbances, focal myocarditis, mitral valve prolapse, pilomatrixomas, polyneuropathy, normal pressure hydrocephalus, and dilatation of the urinary tract. Myotonic dystrophy may show a tendency to familial clustering of organ specific involvement.

Full text

PDF
791

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Aldridge L. M. Anaesthetic problems in myotonic dystrophy. A case report and review of the Aberdeen experience comprising 48 general anaesthetics in a further 16 patients. Br J Anaesth. 1985 Nov;57(11):1119–1130. doi: 10.1093/bja/57.11.1119. [DOI] [PubMed] [Google Scholar]
  2. Beggs A. H., Neumann P. E., Arahata K., Arikawa E., Nonaka I., Anderson M. S., Kunkel L. M. Possible influences on the expression of X chromosome-linked dystrophin abnormalities by heterozygosity for autosomal recessive Fukuyama congenital muscular dystrophy. Proc Natl Acad Sci U S A. 1992 Jan 15;89(2):623–627. doi: 10.1073/pnas.89.2.623. [DOI] [PMC free article] [PubMed] [Google Scholar]
  3. Brunner H. G., Spaans F., Smeets H. J., Coerwinkel-Driessen M., Hulsebos T., Wieringa B., Ropers H. H. Genetic linkage with chromosome 19 but not chromosome 17 in a family with myotonic dystrophy associated with hereditary motor and sensory neuropathy. Neurology. 1991 Jan;41(1):80–84. doi: 10.1212/wnl.41.1.80. [DOI] [PubMed] [Google Scholar]
  4. Bundschu H. D., Hauger W., Lang H. D. Myotonische Dystrophie Curschmann-Steinert. Urologiche Besonderheiten und histochemische Befunde an der Muskulatur. Dtsch Med Wochenschr. 1975 Jun 13;100(24):1337–1341. doi: 10.1055/s-0028-1106383. [DOI] [PubMed] [Google Scholar]
  5. Chiaramonti A., Gilgor R. S. Pilomatricomas associated with myotonic dystrophy. Arch Dermatol. 1978 Sep;114(9):1363–1365. [PubMed] [Google Scholar]
  6. Christensen P. B. Normal pressure hydrocephalus in myotonic dystrophy. Eur Neurol. 1988;28(5):285–287. doi: 10.1159/000116285. [DOI] [PubMed] [Google Scholar]
  7. Cobben J. M., Breuning M. H., Schoots C., ten Kate L. P., Zerres K. Congenital hepatic fibrosis in autosomal-dominant polycystic kidney disease. Kidney Int. 1990 Nov;38(5):880–885. doi: 10.1038/ki.1990.286. [DOI] [PubMed] [Google Scholar]
  8. Dabaghi R. E., Scott L. D. Intestinal pseudo-obstruction in a patient with myotonic dystrophy. Tex Med. 1986 Jun;82(6):42–44. [PubMed] [Google Scholar]
  9. Delfino M., Monfrecola G., Ayala F., Suppa F., Piccirillo A. Multiple familial pilomatricomas: a cutaneous marker for myotonic dystrophy. Dermatologica. 1985;170(3):128–132. doi: 10.1159/000249516. [DOI] [PubMed] [Google Scholar]
  10. Harper P. S. Calcifying epithelioma of Malherbe. Association with myotonic muscular dystrophy. Arch Dermatol. 1972 Jul;106(1):41–44. [PubMed] [Google Scholar]
  11. Hawley R. J., Gottdiener J. S., Gay J. A., Engel W. K. Families with myotonic dystrophy with and without cardiac involvement. Arch Intern Med. 1983 Nov;143(11):2134–2136. [PubMed] [Google Scholar]
  12. KOHN N. N., FAIRES J. S., RODMAN T. UNUSUAL MANIFESTATIONS DUE TO INVOLVEMENT OF INVOLUNTARY MUSCLE IN DYSTROPHIA MYOTONICA. N Engl J Med. 1964 Dec 3;271:1179–1183. doi: 10.1056/NEJM196412032712302. [DOI] [PubMed] [Google Scholar]
  13. Lenard H. G., Goebel H. H., Weigel W. Smooth muscle involvement in congenital myotonic dystrophy. Neuropadiatrie. 1977 Feb;8(1):42–52. doi: 10.1055/s-0028-1091503. [DOI] [PubMed] [Google Scholar]
  14. Moorman J. R., Coleman R. E., Packer D. L., Kisslo J. A., Bell J., Hettleman B. D., Stajich J., Roses A. D. Cardiac involvement in myotonic muscular dystrophy. Medicine (Baltimore) 1985 Nov;64(6):371–387. doi: 10.1097/00005792-198511000-00002. [DOI] [PubMed] [Google Scholar]
  15. Neumann H. P., Wiestler O. D. Clustering of features of von Hippel-Lindau syndrome: evidence for a complex genetic locus. Lancet. 1991 May 4;337(8749):1052–1054. doi: 10.1016/0140-6736(91)91705-y. [DOI] [PubMed] [Google Scholar]
  16. Nowak T. V., Ionasescu V., Anuras S. Gastrointestinal manifestations of the muscular dystrophies. Gastroenterology. 1982 Apr;82(4):800–810. [PubMed] [Google Scholar]
  17. Pruzanski W., Huvos A. G. Smooth muscle involvement in primary muscle disease. I. Myotonic dystrophy. Arch Pathol. 1967 Mar;83(3):229–233. [PubMed] [Google Scholar]
  18. Rausing A. Focal myocarditis in familial dystrophia myotonica. Br Heart J. 1972 Dec;34(12):1292–1294. doi: 10.1136/hrt.34.12.1292. [DOI] [PMC free article] [PubMed] [Google Scholar]
  19. Santis G., Osborne L., Knight R. A., Hodson M. E. Independent genetic determinants of pancreatic and pulmonary status in cystic fibrosis. Lancet. 1990 Nov 3;336(8723):1081–1084. doi: 10.1016/0140-6736(90)92566-z. [DOI] [PubMed] [Google Scholar]
  20. Schneider M., Obringer A. C., Zackai E., Meadows A. T. Childhood neurofibromatosis: risk factors for malignant disease. Cancer Genet Cytogenet. 1986 Apr 15;21(4):347–354. doi: 10.1016/0165-4608(86)90216-5. [DOI] [PubMed] [Google Scholar]
  21. Silverman E. K., Province M. A., Campbell E. J., Pierce J. A., Rao D. C. Variability of pulmonary function in alpha-1-antitrypsin deficiency: residual family resemblance beyond the effect of the Pi locus. Hum Hered. 1990;40(6):340–355. doi: 10.1159/000153958. [DOI] [PubMed] [Google Scholar]
  22. Spaans F., Jennekens F. G., Mirandolle J. F., Bijlsma J. B., de Gast G. C. Myotonic dystrophy associated with hereditary motor and sensory neuropathy. Brain. 1986 Dec;109(Pt 6):1149–1168. doi: 10.1093/brain/109.6.1149. [DOI] [PubMed] [Google Scholar]
  23. Streib E. W., Meyers D. G., Sun S. F. Mitral valve prolapse in myotonic dystrophy. Muscle Nerve. 1985 Oct;8(8):650–653. doi: 10.1002/mus.880080804. [DOI] [PubMed] [Google Scholar]
  24. Vilkki J., Ott J., Savontaus M. L., Aula P., Nikoskelainen E. K. Optic atrophy in Leber hereditary optic neuroretinopathy is probably determined by an X-chromosomal gene closely linked to DXS7. Am J Hum Genet. 1991 Mar;48(3):486–491. [PMC free article] [PubMed] [Google Scholar]
  25. Winters S. J., Schreiner B., Griggs R. C., Rowley P., Nanda N. C. Familial mitral valve prolapse and myotonic dystrophy. Ann Intern Med. 1976 Jul;85(1):19–22. doi: 10.7326/0003-4819-85-1-19. [DOI] [PubMed] [Google Scholar]
  26. Yoshida M. M., Krishnamurthy S., Wattchow D. A., Furness J. B., Schuffler M. D. Megacolon in myotonic dystrophy caused by a degenerative neuropathy of the myenteric plexus. Gastroenterology. 1988 Sep;95(3):820–827. doi: 10.1016/s0016-5085(88)80034-9. [DOI] [PubMed] [Google Scholar]

Articles from Journal of Medical Genetics are provided here courtesy of BMJ Publishing Group

RESOURCES